Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
12.2 EUR | 0.00% | +5.58% | -1.21% |
10/06 | European Equities Traded in the US as American Depositary Receipts Lower in Monday Trading | MT |
05/06 | UBS Upgrades Smith & Nephew to Buy from Neutral, Raises PT | MT |
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-1.21% | 11.4B | - | ||
+15.09% | 133B | A- | ||
-7.39% | 8.3B | C | ||
+42.41% | 5.69B | B+ | ||
-18.37% | 4.78B | C | ||
+7.63% | 3.42B | C- | ||
-20.47% | 2.48B | B- | ||
-14.06% | 2.03B | - | - | |
-30.52% | 1.59B | C- | ||
-12.86% | 1.16B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- SN. Stock
- NPW1 Stock
- Ratings Smith & Nephew Plc